158 related articles for article (PubMed ID: 37855426)
21. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
[TBL] [Abstract][Full Text] [Related]
22. Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
Yoo MR; Gweon HM; Park AY; Cho KE; Kim JA; Youk JH; Son EJ
PLoS One; 2015; 10(6):e0130138. PubMed ID: 26115096
[TBL] [Abstract][Full Text] [Related]
23. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
[TBL] [Abstract][Full Text] [Related]
24. Can Cytologic and Sonographic Features Help Prevent Overtreatment of Bethesda V Thyroid Nodules?
Higgins S; James BC; Sacks B; Mowschenson P; Nishino M; Hasselgren PO
J Surg Res; 2021 Dec; 268():112-118. PubMed ID: 34298210
[TBL] [Abstract][Full Text] [Related]
25. Follow-Up Strategies for Thyroid Nodules with Benign Cytology on Ultrasound-Guided Fine Needle Aspiration: Malignancy Rates of Management Guidelines Using Ultrasound Before and After the Era of the Bethesda System.
Yoon JH; Lee HS; Kim EK; Moon HJ; Park VY; Kwak JY
Thyroid; 2019 Sep; 29(9):1227-1236. PubMed ID: 31359839
[No Abstract] [Full Text] [Related]
26. Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
Kim J; Shin JH; Oh YL; Hahn SY; Park KW
Endocr J; 2022 Jan; 69(1):67-74. PubMed ID: 34408101
[TBL] [Abstract][Full Text] [Related]
27. Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules.
Hu MI; Waguespack SG; Dosiou C; Ladenson PW; Livhits MJ; Wirth LJ; Sadow PM; Krane JF; Stack BC; Zafereo ME; Ali SZ; Weitzman SP; Hao Y; Babiarz JE; Kennedy GC; Kloos RT
J Clin Endocrinol Metab; 2021 Jul; 106(8):2198-2207. PubMed ID: 34009369
[TBL] [Abstract][Full Text] [Related]
28. [Thyroid nodules in children: risk of malignancy for each Bethesda category].
Varela MF; Udaquiola J; Vagni R; Jaén A; Alonso G; Moldes JM; Lobos P; Liberto D
Cir Pediatr; 2019 Jul; 32(3):135-140. PubMed ID: 31486305
[TBL] [Abstract][Full Text] [Related]
29. An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules.
Taccogna S; Papini E; Novizio R; D'Angelo M; Turrini L; Persichetti A; Pontecorvi A; Guglielmi R
Front Endocrinol (Lausanne); 2022; 13():1078019. PubMed ID: 36531453
[TBL] [Abstract][Full Text] [Related]
30. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of fine needle aspiration cytology and histopathology in thyroid nodules at a tertiary care hospital: First report from Somalia.
Abdullahi IM; Yasin NA; Dirken ES; Mohamoud AM; Guler I; Adani AA
Asian J Surg; 2023 Oct; 46(10):4202-4207. PubMed ID: 36504151
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Lobectomy for Bethesda III Thyroid Nodules: Pathological Outcomes and Risk Factors for Malignancy.
Walters BK; Garrett SL; Aden JK; Williams GM; Butler-Garcia SL; Newberry TR; Mckinlay AJ
Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1064-1068. PubMed ID: 33567896
[TBL] [Abstract][Full Text] [Related]
33. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
34. The first Canadian experience with the Afirma® gene expression classifier test.
Kay-Rivest E; Tibbo J; Bouhabel S; Tamilia M; Leboeuf R; Forest VI; Hier MP; Savoury L; Payne RJ
J Otolaryngol Head Neck Surg; 2017 Apr; 46(1):25. PubMed ID: 28372589
[TBL] [Abstract][Full Text] [Related]
35. Can the American Thyroid Association, K-Tirads, and Acr-Tirads Ultrasound Classification Systems Be Used to Predict Malignancy in Bethesda Category IV Nodules?
Yang W; Fananapazir G; LaRoy J; Wilson M; Campbell MJ
Endocr Pract; 2020 Sep; 26(9):945-952. PubMed ID: 33471698
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer.
Schumm MA; Shu ML; Hughes EG; Nikiforov YE; Nikiforova MN; Wald AI; Lechner MG; Tseng CH; Sajed DP; Wu JX; Yeh MW; Livhits MJ
JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):735-742. PubMed ID: 37382944
[TBL] [Abstract][Full Text] [Related]
37. The Incidence of Thyroid Cancer in Bethesda III Thyroid Nodules: A Retrospective Analysis at a Single Endocrine Surgery Center.
Hassan I; Hassan L; Balalaa N; Askar M; Alshehhi H; Almarzooqi M
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786324
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of fine needle aspiration cytology of thyroid nodules.
Erkinuresin T; Demirci H
Diagnosis (Berl); 2020 Jan; 7(1):61-66. PubMed ID: 32037778
[TBL] [Abstract][Full Text] [Related]
39. The clinical significance of the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) category 5 thyroid nodules: Not as risky as we think?
Wright K; Brandler TC; Fisher JC; Rothberger GD; Givi B; Prescott J; Suh I; Patel KN
Surgery; 2023 Jan; 173(1):239-245. PubMed ID: 36511283
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Bethesda System and the ACR TIRADS in an Endemic Goiter Region.
Karaagac M; Sarigoz T; Ertan T; Topuz O
Endocr Res; 2020 Nov; 45(4):226-232. PubMed ID: 32729365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
